Home
About Us
Structure
Current Events
Past Events
Video Gallery
BSCP Students
Policy & Reports
Awards
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
Video Gallery
17th Annual BioPharma & Healthcare Summit, May 03, 2023 - Virtual Edition
  • Welcome address: Karun Rishi, President, USAIC
    Opening comments by Chair and Master of Ceremonies (Emcee): Dr. Andrew Plump

    Welcome address: Karun Rishi, President, USAIC
    Opening comments by Chair and Master of Ceremonies (Emcee): Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

  • Fireside Chat: Dr. Robert Califf moderated by Dr. William Chin

    Fireside Chat: Dr. Robert Califf, Commissioner of Food and Drugs, US Food and Drug Administration
    Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

  • Fireside Chat: Joaquin Duato moderated by Kenneth Frazier

    Fireside Chat: Joaquin Duato, Chairman & CEO, Johnson & Johnson
    Moderator: Kenneth Frazier, Chairman, Health Assurance Initiatives, General Catalyst and former Chairman & CEO, Merck & Co.

  • Fireside Chat: Dr. Albert Bourla moderated by Dr. Stelios Papadopoulos

    Fireside Chat: Dr. Albert Bourla, Chairman and Chief Executive Officer, Pfizer
    Moderator: Dr. Stelios Papadopoulos, Chairman, Biogen

  • Panel: BioPharma R&D and Global Supply Chain agenda at G20

    Panelists:
    Amitabh Kant, G20 Sherpa, G20
    Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech
    Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
    Moderator: 
    Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

  • Panel: Clinical Trials Opportunities in India

    Panelists:
    Badhri Srinivasan, Head, Global Clinical Operations, Novartis
    Dr. Cynthia Verst, President, Design & Delivery Innovation for R&D Solutions, IQVIA
    Dr. Naresh Trehan, Chairman, Medanta - the Medicity
    Dr. Shiv Kumar Sarin, Chancellor, Institute of Liver and Biliary Sciences
    Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog
    Moderator:
    Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical

  • Panel: Research and Development Strategies and Trends

    Panelists:
    Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical
    Dr. Daniel Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, Eli Lilly and Company
    Dr. David Reese, Executive Vice President, Research and Development, Amgen
    Dr. Fiona Marshall, President, Novartis Institutes for BioMedical Research
    Moderator:
    Dr. Martin Mackay, Co-Founder, Rallybio

  • Panel: Industry Academic Partnerships

    Panelists:
    Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health
    Dr. Marcus Schindler, Executive Vice President, Research & Early Development and Chief Scientific Officer, Novo Nordisk
    Dr. Mathai Mammen, CEO Designate, FogPharma
    Dr. Phillip Sharp, Institute Professor, Koch Institute, MIT
    Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
    Moderator:
    Dr. Susan Hockfield, President Emerita, MIT

  • Panel: Digital & Data Science

    Panelists:
    Dr. Alice Zhang, Co-Founder & CEO, Verge Genomics
    Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals
    Dr. Dina Katabi, Professor of Computer Science, Member - CSAIL, Massachusetts Institute of Technology
    Dr. Junaid Bajwa, Chief Medical Scientist, Microsoft
    Sastry Chilukuri former Co-CEO, Medidata

    Moderator:
    Dr. Najat Khan, Chief Data Science Officer and Global Head of Janssen R&D Strategy and Operations, Janssen R&D, Johnson & Johnson

  • Panel: Oncology

    Panelists:
    Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
    Dr. Frank Nestle, Global Head of Research and Chief Scientific Officer, Sanofi
    Dr. Kathy Seidl, Vice President, Head of the Oncology Drug Discovery Unit, Takeda
    Dr. Katy Rezvani, Professor of Medicine, Chief of Section for Cellular Therapy, Director of Translational Research, MD Anderson Cancer Center
    Rehan Verjee, Co-Founder & Chief Executive Officer, Stealth start-up
    Moderator:
    Dr. James Bradner, Physician Scientist, Former President, Novartis Institutes for BioMedical Research

  • Panel: BioPharma Industry & Investment Outlook

    Panelists:
    Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
    Christopher Viehbacher, President & CEO, Biogen
    Rajiv Kaul, Portfolio Manager, Fidelity Investments
    Dr. Stephen Knight, President & Managing Partner, F-Prime Capital
    Theresa Tse, Chairwoman of Board Committee, Sino Biopharmaceutical Limited
    Moderator:
    Dr. Samuel Waksal, Chairman and Chief Executive Officer, Graviton Biosciences

  • Closing Remarks by Dr. Andrew Plump

    Closing Remarks: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceutical


16th Annual BioPharma & Healthcare Summit, June 24, 2022 - Virtual Edition
  • Welcome address: Karun Rishi, President, USAIC

    Welcome address: Karun Rishi, President, USAIC

  • Opening comments by Dr. Andrew Plump

    Opening comments: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals

  • Moving Closer to Cure for More Cancer Patients

    Panelists:
    Dr. Christine Ward, Vice President, Head of Oncology and Cell Therapy, Takeda Pharmaceuticals
    Dr. Eric Rubin, Senior Vice President, Therapeutic Area Head Oncology, Early Development, Merck Research Labs
    Dr. Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics
    Dr. Sam Waksal, Chairman and Chief Executive Officer, Equilibre Biopharmaceuticals
    Dr. Todd Golub, Director and Founding Core Member, Broad Institute of MIT & Harvard

    Moderator:
    Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic

  • Fireside Chat: Alex Gorsky moderated by Christopher Viehbacher

    Fireside Chat: Alex Gorsky, Executive Chairman, Johnson & Johnson
    Moderator: Christopher Viehbacher, Founding Partner, Gurnet Point Capital

  • Clinical Trials Landscape in India

    Panelists:
    Dr. Cynthia Verst, President, Design & Delivery Innovation for Research and Development Solutions, IQVIA
    Dr. Kush Parmar, Managing Partner, 5AM Ventures
    Dr. Naresh Trehan, Chairman, Medanta
    Peter Ronco, Head of Global Development, Janssen Research and Development, Johnson & Johnson
    Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog

    Moderator:
    Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals

  • Digital & Data Science Panel

    Panelists:
    Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
    Dr. Karen Akinsanya, President of Research and Development, Therapeutics, Schrodinger
    Dr. Regina Barzilay, Professor of AI and Health, Massachusetts Institute of Technology
    Sastry Chilukuri, Co-Chief Executive Officer, Medidata
    Dr. Vipin Gopal, Chief Data & Analytics Officer, Eli Lilly

    Moderator:
    Chris Benko, Co-Founder and Chief Executive Officer, Koneksa Health

  • Pandemics: Where does the world go from here

    Panelists:
    Dr. Larry Tabak, Acting Director, National Institutes of Health (NIH)
    Dr. John Mascola, Chief Scientific Officer, ModeX Therapeutics
    Dr. Julie Gerberding, Chief Executive Officer, Foundation for the NIH (FNIH)
    Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

    Moderator:
    Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University

  • Industry & Investment Outlook Panel

    Panelists:
    Christopher Viehbacher, Founding Partner, Gurnet Point Capital
    Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
    Rajiv Kaul, Portfolio Manager, Fidelity Investments
    Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

    Moderator:
    Jennifer Fox, Chief Financial Officer, Nuvation Bio

  • Rethinking Rare: Resolutions for reinvention in a genomic age

    Panelists:
    Dr. Alfred Sandrock, Chief Executive Officer, Voyager Therapeutics
    Charlene Son Rigby, Chief Executive Officer, RARE-X
    Paula Soteropoulos, Chairman of the Board, Ensoma
    Dr. Philip Larsen, Global Head of Research, Bayer Pharma
    Max Bronstein, Assistant Director for Health Innovation, White House Office of Science & Technology Policy

    Moderator:
    Dr. Timothy Yu, Associate Professor in Pediatrics, Harvard Medical School

  • Research and Development Strategies & Trends Panel

    Panelists:
    Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
    Dr. David Reese, Executive Vice President, Research and Development, Amgen
    Dr. John Reed, Global Head of Research and Development, Sanofi
    Dr. Mathai Mammen, Executive Vice President, Pharmaceuticals, Research and Development, Johnson & Johnson

    Moderator: 
    Dr. Martin Mackay, Co-Founder, Rallybio

  • Closing Remarks

    Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals, Advisory Board Members and Speakers


15th Annual BioPharma & Healthcare Summit, June 22, 2021 - Virtual Edition
  • Welcome address by Karun Rishi, President, USAIC

    Welcome address: Karun Rishi, President, USAIC

  • Opening comments by Dr Andrew Plump

    Opening comments: Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

  • Fireside Chat with Dr. Albert Bourla moderated by Dr. Stelios Papadopoulos

    Dr. Albert Bourla, Chairman & CEO, Pfizer
    Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

  • Fireside Chat with Dr. Janet Woodcock moderated by Dr. William Chin

    Dr. Janet Woodcock, Acting Commissioner, U.S. Food and Drug Administration
    Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

  • R&D Strategies & Trends Panel

    Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals, Dr. David Reese, Executive Vice President, Research and Development, Amgen, Dr. John Reed, Global Head of R&D, Sanofi, Dr. Mathai Mammen, Global Head of Janssen R&D, Johnson & Johnson
    Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

  • India Innovation Panel

    Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India, Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries Limited, Prof. K. Vijay Raghavan, Principal Scientific Advisor, Government of India, Dr. Naresh Trehan, Chairman, Medanta Hospital
    Moderator: Sanat Chattopadhyay, President- Merck Manufacturing Division, Merck & Co.

  • Fireside Chat: Robert Bradway moderated by Kiran Mazumdar-Shaw

    Fireside Chat: Robert Bradway, Chairman & CEO, Amgen
    Moderator: Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

  • Fireside Chat with Dr. Francis Collins moderated by Dr. Elias Zerhouni

    Fireside Chat: Dr. Francis Collins, Director, National Institutes of Health, Dr. Margaret Hamburg, Former Commissioner, U.S. Food and Drug Administration
    Moderator: Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University

  • Oncology Panel

    Panelists: Dr. Bruce Chabner, Director of Clinical Research, Massachusetts General Hospital Cancer Center, Dr. Carrie Brownstein, Chief Medical Officer, Cellectis, Dr. Philip Larsen, Global Head of Research, Bayer AG, Dr. Sam Waksal, Founder, MeiraGTx, Vivek Ramaswamy, Founder & Executive Chairman, Roivant Sciences
    Moderator: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic

  • Industry & Investment Outlook Panel

    Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital, Dr. Peter Orszag, Chief Executive Officer - Financial Advisory, Lazard Freres, Rajiv Kaul, Portfolio Manager, Fidelity Investments, Dr. Stelios Papadopoulos, Chairman, Biogen
    Moderator: Daphne Zohar, Co-Founder and Chief Executive Officer, PureTech Health

  • Digital & Data Science Panel

    Panelists: Craig Kennedy, Senior Vice President, Merck & Co., Dr. Daphne Koller, Founder & CEO, insitro, Dr. Karen Akinsanya, Chief Biomedical Scientist, Schrödinger, Dr. Najat Khan, Chief Data Science Officer, Janssen Research & Development, Dr. Robert Califf, Head of Clinical Policy & Strategy, Verily & Google Health
    Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

  • Rare Disease Panel

    Panelists: Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals, Dr. Frank Bennett, Chief Scientific Officer, Ionis Pharmaceuticals, Dr. John Orloff, Head of Research & Development, Alexion, Dr. Katherine High, President - Therapeutics, AskBio, Majid Jafar, Co-Founder, Loulou Foundation
    Moderator: Dr. Alfred Sandrock, Head of Research and Development, Biogen
     

  • Closing Remarks by Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

14th Annual BioPharma & Healthcare Summit, September 4, 2020 - Virtual Edition
 
  • Welcome address by Karun Rishi, President, USAIC
  • Opening Address by Andrew Plump

    Opening comments Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

  • COVID-19 panel- Where are we now? Where are we going?

    Panelists: Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health; Dr. George Yancopoulos, Co-Founder, President & CSO, Regeneron; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; Dr. Rajeev Venkayya, President of the Global Vaccine Business Unit, Takeda; Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)
    Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

  • India Regulatory Update

    Dr. Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, India; Dr. V G Somani, Drug Controller General of India, Central Drug Control Organization
    Moderator: Muna Bhanji, Senior Vice President,  Merck & Co.

  • Fireside Chat with Kenneth Frazier moderated by Stelios Papadopoulos

    Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co.
    Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

  • India Innovation Landscape Panel

    Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India (NITI); Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Dr. K. Vijay Raghavan, Principal Scientific Advisor, Government of India; Dr. Naresh Trehan, Chairman, Medanta - the Medicity
    Moderator: Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.

  • Oncology panel discussion: Changing landscape- COVID learnings and the promise of new technologies

    Panelists: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic; Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute; Dr. Philip Larsen, Global Head of Research, Bayer AG; Rehan Verjee, President, EMD Serono; Dr. Tony Ho, Head of Research and Development, CRISPR Therapeutics
    Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

  • Industry & Investment Outlook Panel Discussion

    Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital; Daphne Zohar, Founder & CEO, PureTech Health; Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University; Dr. Stelios Papadopoulos, Chairman, Biogen
    Moderator: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

  • Rare Diseases panel: No longer forgotten; but more to be achieved

    Panelists: Dr. Alfred Sandrock, Executive Vice President, Research & Development, Biogen; Dr. Daniel Curran, Head of the Rare Diseases Therapeutic Area Unit, Takeda; Dr. David Meeker, Chairman & CEO , Rhythm Pharmaceuticals; Dr. John Orloff, Head of Research & Development, Alexion; Matt Wilsey, Co-Founder & Chairman, Grace Science Foundation
    Moderator: Dr. Steve Uden, Co-Founder, Rallybio

  • Fireside Chat with Roy Vagelos moderated by Mathai Mammen

    Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals
    Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson

  • Digital & Data Science in Healthcare Panel: Pragmatic Insights from the Real-World

    Panelists: Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals; Arpa GarayPresident, Global Pharmaceuticals, Commercial Analytics, Merck & Co.; Dr. Maya Said, Chief Executive Officer, Outcomes4Me; Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson; Nina Kjellson, General Partner, Canaan
    Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

  • R&D Strategies and Trends Panel: Innovation- The Big I

    Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals; Dr. David Reese, Executive Vice President, Research and Development, Amgen; Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline; Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson
    Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

  • Closing Remarks by Andrew Plump, President of R&D, Takeda
© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Media Coverage | Legal | Contact us